Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Tuberc Lung Dis. 2002 Aug;6(8):649-50.

Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?

Author information

  • 1Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, UK.

Comment in

PMID:
12150473
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Ingenta plc
    Loading ...
    Write to the Help Desk